Supplemental Figure 2 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Marta Sonia González
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
163Publications signalées
564Citations signalées
0Affiliations récentes
Les domaines associés
Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsMyeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchPeptidase Inhibition and Analysis
Les publications récentes
Supplemental Table 7 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 4 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 6 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 8 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Figure 1 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 2 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 9 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 1 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 3 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Supplemental Table 5 from Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma
Camila Guerrero, María José Larráyoz, Irache Erdozain, Noemí Puig et autres
0 citations
Linvoseltamab (LINVO) + bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial.
Paula Rodríguez‐Otero, Sosana Delimpasi, Albert Oriol, Meletios Α. Dimopoulos et autres
es, gr, fr, us (code pays fourni par la source)
1 citation
Journal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.